Pediatric Cancer
Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests
Research presented at ASHG suggested that germline cancer susceptibility profiling may help to predict survival outcomes for a subset of rhabdomyosarcoma cases.
Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer
The analysis also found that about half the sibling deaths due to cancer could be averted by surveillance following cascade testing, as compared to usual care.
A multiomic study out of TGen and the Beat Childhood Cancer Research Consortium found potentially actionable tumor changes at the point of disease relapse.
A recent $4 million grant will help double the size of the database, which is already helping researchers study links between genetic ancestry and cancer treatment outcomes.
Jazz Pharmaceuticals, SU2C Partner on Research on RAF Inhibitors, Pediatric Solid Cancer
The $4 million collaboration will focus on advancing research on Jazz's pan-RAF inhibitor JZP815, its approved agent Zepzelca, and clinical trial access disparities.